The FDA-cleared electrocardiogram (ECG) monitor has been designed in collaboration with global design firm IDEO, based on first-hand customer feedback.

University of California San Francisco heart and vascular center cardiology division co-director Jeffrey Olgin said: "The AliveCor Heart Monitor leads to results that I can use to manage my patients remotely, a trend that is here to stay.

"Seeing my patients’ ECG results in real-time is the next best thing to having them in my office when the event takes place."

The monitor also displays ECG rhythms and detects the presence of atrial fibrillation, and it can be used by healthcare professionals, patients with known or suspected heart conditions and health conscious individuals.

The new heart monitor is compatible with the free AliveECG app and it will be available on Amazon and through AliveCor’s collaboration with Omron Healthcare, a manufacturer of home blood pressure monitors.

AliveCor president and CEO Euan Thomson said: "Big data and personalized medicine are revolutionizing the delivery of care and have the potential to disrupt the way we think about healthcare.

"The newest generation of the Heart Monitor confirms AliveCor’s ongoing commitment to help stop the unnecessary loss of life and healthcare costs driven by undiagnosed and under-managed heart arrhythmias that lead to potentially life-threatening conditions like strokes."

The new mobile ECG device is available at the price of $74.99 and is not intended for pediatric use, said AliveCor.

Image: Third generation AliveCor Heart Monitor. Photo: courtesy of PRNewswire/ AliveCor, Inc.